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Case Presentation

A 31 year-old Caucasian male with no significant past medical
history presents with increasing dizziness, chest pain, and
shortness of breath of one day duration. On returning from a
camping trip to Northern Pennsylvania three weeks prior to
admission, he noted high fevers, “joint pains all over,” and a pink
blotchy rash all over his chest and back. He did not recall any
insect, tick or animal bites. His primary physician, who clinically
suspected Lyme disease, ordered Lyme serologies and offered a
prescription for doxycycline which the patient declined. Two
weeks later, the patient presented to the emergency department
after the onset of chest pain that he described as sharp, radiating
to both arms, occurring with exertion and relieved by rest. The
chest pain was associated with worsening shortness of breath
and dizziness.
The patient denied taking any medications, herbal or other
supplements. He admitted to smoking half a pack of cigarettes per
day, drinking 20 alcoholic beverages per week and occasionally
smoking marijuana. He denied any intravenous drug use. He also
denied any recent travel outside the United States or exposures
to new chemicals or pets. The patient’s mother had leukemia; his

father had hypertension, diabetes, and hyperlipidemia; and his
brother died from an anaphylactic reaction to shellfish.
On physical exam, the patient had a temperature of 99.6°
Fahrenheit, heart rate of 50 beats/minute, blood pressure of
155/77 mm Hg, respiratory rate of 14 breaths/minute with
an oxygen saturation of 100% on room air. The exam also
revealed a regularly irregular rhythm with no murmurs, rubs
or gallops. His lungs were clear to auscultation bilaterally. He
had no focal neurological deficits nor was he orthostatic. Large,
well demarcated macular erythematous lesions were noted
on his back and thorax. Initial labs showed a white blood cell
count of 10,000 cells/mm3 with a normal differential, normal
serum chemistries, and a negative troponin. Peripheral smear
was negative for babesiosis. The patient’s admission chest
radiograph showed clear lungs without evidence of infiltrate or
effusion. His initial EKG (Figure 1) showed a sinus rhythm at
an atrial rate of approximately 100 beats/minute and a highgrade atrioventricular (AV) block with a variable ventricular
response of about 40 beats/minute. The patient was admitted
to telemetry, and a transcutaneous pacer was placed. Empiric
intravenouis ceftriaxone was begun to treat for a clinical
diagnosis of Lyme carditis.

Figure 1. The patient’s admission EKG showed high grade AV block with variable conduction.
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Figure 2. EKG on hospital day two showed second degree AV Block with 2:1 conduction.
Lyme IgM and IgG antibody titers were positive, but Lyme
PCR was negative. A transthoracic echocardiogram revealed
mild mitral regurgitation, normal left ventricular size and
thickness with hyperdynamic function. His ejection fraction
was approximately 85%. By day two of hospitalization, his EKG
had changed to sinus rhythm and second degree AV Block with
2:1 conduction (Figure 2). He was treated with intravenous
ceftriaxone for 28 days with follow up in the cardiologic clinic
two weeks after discharge. The repeat EKG at the follow up visit
showed a return to normal sinus rhythm (Figure 3).

Figure 3. The patient’s follow up EKG illustrates normal sinus
rhythm.
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Discussion

Lyme disease is a multi-system spirochetal infection caused by
Borrelia burgdorferi affecting up to 20,000 Americans each year.
A Diagnosis of Lyme disease requires a high index of suspicion
and a good history. The majority of patients will report travel
to an endemic region, but many will not recall a tick bite.1,2,3
Upon exposure, patients enter an asymptomatic incubation
phase (lasting from three to 32 days). This phase is identified
only by a localized skin reaction at the site of inoculation that is
secondary to spirochetal infiltration of the dermis and epidermis.3
Following this, patient presentation varies depending on the
phase of the disease. Table 1 depicts the symptoms associated
with subsequent phases of Lyme disease if left untreated.
Our patient’s symptomatology places him in the “Early
Disseminated Phase,” presenting with fluctuating AV block
ranging from first degree heart block to high grade AV dissociation
with variable conduction. Cardiovascular complications may
occur in up to 8% of patients with untreated Lyme disease.10 AV
block is the most common cardiovascular manifestation of Lyme
disease, attributed to spirochetal infiltration of the conduction
system.4 AV block secondary to Lyme disease is considered to
be transient and is expected to resolve with treatment of the
underlying disease.5
While AV block is the most common cardiovascular
manifestation of Lyme disease,6 patients may also present with
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Table 1. Clinical Features of Lyme disease
Early Localized Phase

Early Disseminated Phase

Late Disseminated or Chronic

(months to years)

(days to weeks)

(weeks to months)

Cardiac

(none)

Atrioventricular block; myopericarditis;
pancarditis

(none)

Constitutional

Influenza-like symptoms

Malaise; fatigue

Fatigue

Lymphatic

Regional lymphadenopathy

Regional or generalized lymphadenopathy

(none)

Musculoskeletal

Myalgia

Migratory pain in joints, bone, muscle;
brief arthritis attacks

Prolonged oligoarticular arthritis
with frequent flares

Neurologic

Headache

Meningitis; Encephalitis,
Meningoencephalitis; Bell’s palsy;
cranial neuritis; radiculoneuritis

Encephalopathy; polyneuropathy;
leukoencephalitis; Dementia; Mood
Disorder

Skin

Localized skin reaction,
Erythema migrans

Secondary annular lesions

Lymphocytoma; acrodermatitis
chronica atrophicans

System

Adapted from Steere AC. Lyme disease. N Engl J Med 1989;321:589.

myopericarditis, left ventricular dysfunction, cardiomegaly,
pancarditis, aortitis, as well as ventricular tachyarrythmias.4,7,8
The exact reason for variability in presentation is unknown,
but is theorized to be secondary to the location and degree of
spirochetal infiltration as evidenced by cardiac biopsies of nonhuman primates with Lyme disease.9 Histopathologic stains
of these biopsies show infiltration of the Borrelia spirochete
from all regions of the heart, including aorta, atrium, and
myocardium.9

Conclusion

Because of the potential for life-threatening complications,
hospitalization and continuous monitoring are advisable for
symptomatic patients (e.g., those with syncope, dyspnea, or
chest pain). These interventions are also suggested for patients
with second or third degree AV block, as well as for those with
first degree heart block when the PR interval is prolonged by
more than 30 milliseconds because the degree of block may
fluctuate and worsen very rapidly in such patients.12
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